Kinases as drug targets in the treatment of bipolar disorder

Drug Discovery Today
Lisa A Catapano, Husseini K Manji

Abstract

Bipolar disorder is one of the most severely debilitating of all medical illnesses, and is increasingly recognized as a major public health problem. For many patients with bipolar disorder, current pharmacotherapy is insufficient. Exciting recent data suggest that regulation of signaling molecules may be involved in the pathophysiology of the disorder, and in the mechanisms of action of mood stabilizers and antidepressants. Through our developing understanding of the biochemical targets of effective medications, several potential targets for new therapies have emerged. This short review will focus on two of the most promising such targets: glycogen synthase-3 and protein kinase C.

References

Nov 1, 1979·Pharmakopsychiatrie, Neuro-Psychopharmakologie·A JohnssonW Klemke
Feb 1, 1987·The American Journal of Psychiatry·T A WehrN E Rosenthal
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·P S Klein, D A Melton
May 1, 1997·Developmental Biology·C M HedgepethP S Klein
Oct 6, 1997·The Journal of Biological Chemistry·M HongV M Lee
Dec 3, 1999·European Journal of Biochemistry·A MoraF Centeno
Jan 13, 2000·Archives of General Psychiatry·J M BebchukH K Manji
Nov 10, 2000·Lancet·G J MooreH K Menji
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·P Cohen, S Frame
Apr 17, 2002·The Journal of Cell Biology·Britta J EickholtPatrick Doherty
Jun 4, 2002·Nature Medicine·Joseph T Coyle, Husseini K Manji
Jun 20, 2002·Bipolar Disorders·Xiaohua LiRichard S Jope
Oct 11, 2002·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Todd D Gould, Husseini K Manji
Nov 21, 2002·Pharmacology & Therapeutics·Nadia Gurvich, Peter S Klein
Dec 31, 2002·Investigative Ophthalmology & Visual Science·Xizhong HuangDong Feng Chen
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Myoung-Sun RohYong Sik Kim
Feb 4, 2003·Nature Reviews. Drug Discovery·Chris J VlahosAngela Clerk
Mar 5, 2003·Journal of Cell Science·Bradley W Doble, James R Woodgett
May 10, 2003·Journal of Affective Disorders·Alison JacksonJan Scott
May 23, 2003·Nature·Christopher J PhielPeter S Klein
Aug 28, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Todd D GouldHusseini K Manji
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jean-Martin BeaulieuMarc G Caron
Apr 23, 2004·Trends in Biochemical Sciences·Richard S Jope, Gail V W Johnson
Jun 3, 2004·Nature Reviews. Drug Discovery·Philip Cohen, Michel Goedert
Aug 19, 2004·The International Journal of Neuropsychopharmacology·Todd D GouldHusseini K Manji
Nov 24, 2004·Trends in Pharmacological Sciences·Laurent MeijerPaul Greengard
Jan 18, 2005·Cell·Takeshi YoshimuraKozo Kaibuchi
Apr 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Todd D Gould, Husseini K Manji
May 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Wendy NobleKaren Duff
May 9, 2006·European Journal of Pharmacology·Justin S LaiPeter P Li
Oct 24, 2006·Current Opinion in Pharmacology·Galit ShaltielHusseini K Manji
Nov 15, 2006·Current Drug Targets·Lisa KockeritzJames R Woodgett
Nov 15, 2006·Current Drug Targets·Hui-Chuan Huang, Peter S Klein
Nov 15, 2006·Current Drug Targets·Richard S Jope, Myoung-Sun Roh
Dec 6, 2006·Cancer Research·Eugenia M YazlovitskayaDennis E Hallahan

❮ Previous
Next ❯

Citations

Jun 25, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Laura CaberlottoMaria Razzoli
Aug 25, 2012·Analytical and Bioanalytical Chemistry·Elinor MeibySten Ohlson
Nov 4, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Heather C WhalleyAndrew M McIntosh
Oct 31, 2009·Nature Reviews. Drug Discovery·Laura K ChicoD Martin Watterson
Aug 9, 2011·Annual Review of Pharmacology and Toxicology·Feng CongShih-Min A Huang
May 28, 2016·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Ayşegül YildizPerry Renshaw
Apr 7, 2011·Neuropharmacology·Kirsty J MartinJ Simon C Arthur
Jul 15, 2009·Drug Discovery Today·Marcus BantscheffAlbert J R Heck
Jan 1, 2013·Computational and Structural Biotechnology Journal·Valère LounnasNicolas Foloppe
Jan 7, 2011·The International Journal of Neuropsychopharmacology·Mikhail Kalinichev, Lee A Dawson
Jun 13, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Jeverson MoreiraCynthia Marie-Claire
Feb 10, 2011·Pharmacological Reviews·Jean-Martin Beaulieu, Raul R Gainetdinov
Nov 16, 2013·Experimental & Molecular Medicine·Brian T D TobeEvan Y Snyder
Nov 3, 2010·Analytical Chemistry·Mikhail M SavitskiMarcus Bantscheff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.